Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Pediatric Solid Tumors”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Early research (Phase 1)WithdrawnNCT01130623
What this trial is testing

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07630974
What this trial is testing

Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 134
Early research (Phase 1)UnknownNCT02897986
What this trial is testing

Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors

Who this might be right for
Pediatric Cancer
Assistance Publique Hopitaux De Marseille 54
Testing effectiveness (Phase 2)UnknownNCT02638428
What this trial is testing

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Who this might be right for
Relapsed Pediatric Solid TumorRefractory Pediatric Solid TumorRelapsed Pediatric AML+1 more
Samsung Medical Center 90
Not applicableStudy completedNCT02846038
What this trial is testing

Understanding Communication in Healthcare to Achieve Trust (U-CHAT)

Who this might be right for
Brain TumorsSolid Tumor
St. Jude Children's Research Hospital 138
Early research (Phase 1)Study completedNCT02677116
What this trial is testing

Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer

Who this might be right for
Neoplasm Metastasis
Eli Lilly and Company 68
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Early research (Phase 1)Study completedNCT01240538
What this trial is testing

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 26
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Early research (Phase 1)Study completedNCT00079404
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Who this might be right for
Acute Undifferentiated LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid Leukemia+2 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT02076906
What this trial is testing

MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors

Who this might be right for
Relapsed Pediatric Solid TumorsRefractory Pediatric Solid TumorsRhabdomyosarcoma+7 more
AeRang Kim 7
Early research (Phase 1)Study completedNCT01683149
What this trial is testing

Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies

Who this might be right for
Solid Tumor
H. Lee Moffitt Cancer Center and Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT00106353
What this trial is testing

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Who this might be right for
AdenocarcinomaNeoplasms
Pfizer 71
Testing effectiveness (Phase 2)WithdrawnNCT02747537
What this trial is testing

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

Who this might be right for
Pediatric Solid Tumors
Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT04773782
What this trial is testing

Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling

Who this might be right for
Solid Tumor, Unspecified, ChildRelapsed Solid NeoplasmCNS Tumor
Blueprint Medicines Corporation 29
Early research (Phase 1)WithdrawnNCT02800889
What this trial is testing

Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer

Who this might be right for
LymphomaSolid Tumor (Excluding CNS)
CTI BioPharma
Early research (Phase 1)Not Yet RecruitingNCT06710821
What this trial is testing

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Who this might be right for
Solid Tumor Cancer
Yizhuo Zhang 40
Early research (Phase 1)Looking for participantsNCT05608148
What this trial is testing

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Who this might be right for
Refractory/Relapse NeuroblastomaPediatric Solid Tumors
Kyushu University 61
Testing effectiveness (Phase 2)Looking for participantsNCT02332668
What this trial is testing

Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Who this might be right for
MelanomaLymphomaSolid Tumor+2 more
Merck Sharp & Dohme LLC 370
Early research (Phase 1)Study completedNCT02379416
What this trial is testing

Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid Tumors

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 47
Load More Results